355
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Stability of Amoxicillin and Clavulanic Acid in Separate Containers for Administration via a Y-Site

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 3979-3984 | Published online: 21 Sep 2021

References

  • CarbónC. Single-dose antibiotic therapy: what has the past taught us?J Clin Pharmacol. 1992;32:686–691. doi:10.1002/j.1552-4604.1992.tb03870.x1487556
  • VincentJ-L. Intensive Care Medicine: Annual Update 2002. Springer Science & Business Media; 2003.
  • RelloJ, KollefMH, DíazE, RodríguezA. Infectious Diseases in Critical Care. Springer Science & Business Media; 2010.
  • TurnidgeJD. The pharmacodynamics of β-Lactams. Clin Infect Dis. 1998;27(1):10–22. doi:10.1086/5146229675443
  • CraigWA. State-of-the-art clinical article: pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis. 1998;26:1–10. doi:10.1086/5162849455502
  • VegaEM, ManzoRH, SolaN. Improving the stability of potassium clavulanate in admixture with amoxicillin. Hosp Pharm. 2008;15:183–185.
  • MacgowanAP, BowkerKE. Continuous infusion of β-lactam antibiotics. Clin Pharmacokinet. 1998;35:391–402. doi:10.2165/00003088-199835050-000049839090
  • YoungRJ, LipmanJ, GinT, GomersallCD, JoyntGM, OhTE. Intermittent bolus dosing of ceftazidime in critically ill patients. J Antimicrob Chemother. 1997;40:269–273. doi:10.1093/jac/40.2.2699301994
  • FantinB, FarinottiR, ThabautA, CarbonC. Conditions for the emergence of resistance to cefpirome and ceftazidime in experimental endocarditis due to pseudomonas aeruginosa. J Antimicrob Chemother. 1994;33:563–569. doi:10.1093/jac/33.3.5638040120
  • FawazS, BartonS, WhitneyL, SwindenJ, Nabhani-GebaraS. Stability of meropenem after reconstitution for administration by prolonged infusion. Hosp Pharm. 2018;54:1–7. doi:10.1177/0018578718779009
  • FawazS, DixonB, BartonS, MohamedA, Nabhani-GebaraS. Suitability of amoxicillin–clavulanic acid for administration via prolonged infusion. Drug Des Devel Ther. 2020;14:103–109. doi:10.2147/DDDT.S230459
  • Sabbagh Dit HawasliR, BartonS, Nabhani-GebaraS. Ambulatory chemotherapy: past, present, and future. J Oncol Pharm Pract. 2021;107815522098591. doi:10.1177/1078155220985916
  • CarlierM, VerstraeteAG, De WaeleJJ, StoveV. Stability of amoxicillin and amoxicillin/clavulanic acid reconstituted in isotonic saline. J Chemother. 2017;29(1):54–56. doi:10.1179/1973947815y.000000005226032969
  • VahdatL, SunderlandVB. Kinetics of amoxicillin and clavulanate degradation alone and in combination in aqueous solution under frozen conditions. Int J Pharm. 2007;342(1–2):95–104. doi:10.1016/j.ijpharm.2007.05.02917592747
  • VahdatL, SunderlandB. The influence of potassium clavulanate on the rate of amoxicillin sodium degradation in phosphate and acetate buffers in the liquid state. Drug Dev Ind Pharm. 2009;35:471–479. doi:10.1080/0363904080243837319048426
  • PatersonIK, HoyleA, OchoaG, Baker-AustinC, TaylorNGH. Optimising antibiotic usage to treat bacterial infections. Sci Rep. 2016;6:1–10. doi:10.1038/srep3785328442746
  • GillespieEL, KutiJL, NicolauDP. Pharmacodynamics of antimicrobials: treatment optimisation. Expert Opin Drug Metab Toxicol. 2005;1(3):351–361. doi:10.1517/17425255.1.3.35116863448
  • KambiaNK, MeriteN, DineT, et al. Stability studies of amoxicillin/clavulanic acid combination in polyolefin infusion bags. Eur J Hosp Pharm. 2010;16:30–37.
  • NurAO, HassaonAAA, GadkariemEA, OsmanZ, AliGKM. Stability of co-amoxiclav reconstituted injectable solution. Eur J Pharm Med Res. 2015;2:109–123.
  • AdamD, De VisserI, KoeppeP. Pharmacokinetics of amoxicillin and clavulanic acid administered alone and in combination. Antimicrob Agents Chemother. 1982;22(3):353–357. doi:10.1128/AAC.22.3.3537137979